Suzetrigine-enhanced MultimOdal Opioid-sparing THerapy in Cardiac and Bariatric SURGery

This is prospective, randomized study. The purpose of this study is to evaluate whether the addition of Suzetrigine to well established multimodal pain regimen for participants undergoing bariatric patients undergoing weight-loss surgery and cardiac patients undergoing sternotomy will reduce post-operative opioid consumption and pain scores.

NCT Number	NCT07539623
Lead Sponsor	Icahn School of Medicine at Mount Sinai
Conditions	Bariatric Surgery, Cardiac Surgery With Sternotomy, Post-operative Pain
Enrollment	235 participants
Start Date	2026-05-01
Primary Completion	2026-12-22 (estimated)
Study Completion	2026-12-22 (estimated)
Updated on ClinicalTrials.gov	2026-05-14